Heike Niessner

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 16

Top Topics

Top Venues

Antioxidants (Basel, Switzerland)

Experimental dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Markus Burkard, Heike Niessner, Christian Leischner, Alban Piotrowsky, Olga Renner, Luigi Marongiu, Ulrich M Lauer, Christian Busch, Tobias Sinnberg, Sascha Venturelli
High-Dose Ascorbate in Combination with Anti-PD1 Checkpoint Inhibition as Treatment Option for Malignant Melanoma. Cells 12 (2) (2023)
Markus Burkard, Heike Niessner, Christian Leischner, Alban Piotrowsky, Olga Renner, Luigi Marongiu, Ulrich M Lauer, Christian Busch, Tobias Sinnberg, Sascha Venturelli
High-Dose Ascorbate in Combination with Anti-PD1 Checkpoint Inhibition as Treatment Option for Malignant Melanoma. Cells 12 (2) (2023)
Markus Burkard, Heike Niessner, Christian Leischner, Alban Piotrowsky, Olga Renner, Luigi Marongiu, Ulrich M Lauer, Christian Busch, Tobias Sinnberg, Sascha Venturelli
High-Dose Ascorbate in Combination with Anti-PD1 Checkpoint Inhibition as Treatment Option for Malignant Melanoma. Cells 12 (2) (2023)
Heike Niessner, Anna Hüsch, Corinna Kosnopfel, Matthias Meinhardt, Dana Westphal, Friedegund Meier, Bastian Schilling, Tobias Sinnberg
Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated Melanoma. Cancers 15 (23) (2023)
Lisa Marie Fröhlich, Heike Niessner, Birgit Sauer, Sofie Kämereit, Eftychia Chatziioannou, Simon Riel, Tobias Sinnberg, Birgit Schittek
PARP Inhibitors Effectively Reduce MAPK Inhibitor Resistant Melanoma Cell Growth and Synergize with MAPK Inhibitors through a Synthetic Lethal Interaction In Vitro and In Vivo . Cancer research communications 3 (9) (2023)
Christian Leischner, Steffen Plunder, Alban Piotrowsky, Heike Niessner, Sascha Venturelli, Markus Burkard, Olga Renner
Relevant Membrane Transport Proteins as Possible Gatekeepers for Effective Pharmacological Ascorbate Treatment in Cancer. Antioxidants (Basel, Switzerland) 12 (4) (2023)
Christian Leischner, Steffen Plunder, Alban Piotrowsky, Heike Niessner, Sascha Venturelli, Markus Burkard, Olga Renner
Relevant Membrane Transport Proteins as Possible Gatekeepers for Effective Pharmacological Ascorbate Treatment in Cancer. Antioxidants (Basel, Switzerland) 12 (4) (2023)
Heike Niessner, Markus Burkard, Christian Leischner, Olga Renner, Sarah Plöger, Francisco Meraz-Torres, Matti Böcker, Constanze Hirn, Ulrich M Lauer, Sascha Venturelli, Christian Busch, Tobias Sinnberg
Therapeutic Efficacy of Pharmacological Ascorbate on Braf Inhibitor Resistant Melanoma Cells In Vitro and In Vivo. Cells 11 (7) (2022)
Tobias Sinnberg, Christa Lichtensteiger, Katharina Hill-Mündel, Christian Leischner, Heike Niessner, Christian Busch, Olga Renner, Nina Wyss, Lukas Flatz, Ulrich M Lauer, Ludwig E Hoelzle, Donatus Nohr, Markus Burkard, Luigi Marongiu, Sascha Venturelli
Vitamin C Deficiency in Blood Samples of COVID-19 Patients. Antioxidants (Basel, Switzerland) 11 (8) (2022)
Marisa Schmitt, Tobias Sinnberg, Heike Niessner, Andrea Forschner, Claus Garbe, Boris Macek, Nicolas C Nalpas
Individualized Proteogenomics Reveals the Mutational Landscape of Melanoma Patients in Response to Immunotherapy. Cancers 13 (21) (2021)
Annie Lauer, Markus Burkard, Heike Niessner, Christian Leischner, Olga Renner, Claudia Vollbracht, Holger Michels, Christian Busch, Tobias Sinnberg, Sascha Venturelli
Ex Vivo Evaluation of the Sepsis Triple Therapy High-Dose Vitamin C in Combination with Vitamin B1 and Hydrocortisone in a Human Peripheral Blood Mononuclear Cells (PBMCs) Model. Nutrients 13 (7) (2021)
Christian Leischner, Markus Burkard, Anja Michel, Susanne Berchtold, Heike Niessner, Luigi Marongiu, Christian Busch, Theresia Jumbe, Ulrich M Lauer, Sascha Venturelli
Comparative Analysis of the Antitumor Activity of Cis- and Trans-Resveratrol in Human Cancer Cells with Different p53 Status. Molecules (Basel, Switzerland) 26 (18) (2021)
Franz J Hilke, Tobias Sinnberg, Axel Gschwind, Heike Niessner, German Demidov, Teresa Amaral, Stephan Ossowski, Irina Bonzheim, Martin Röcken, Olaf Riess, Claus Garbe, Christopher Schroeder, Andrea Forschner
Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma Patients. Cancers 12 (9) (2020)
Francisco Meraz-Torres, Sarah Plöger, Claus Garbe, Heike Niessner, Tobias Sinnberg
Disulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma-Old Myth or New Logos? Cancers 12 (12) (2020)
Heike Niessner, Corinna Kosnopfel, Tobias Sinnberg, Daniela Beck, Kathrin Krieg, Ines Wanke, Konstantinos Lasithiotakis, Michael Bonin, Claus Garbe, Friedegund Meier
Combined activity of temozolomide and the mTOR inhibitor temsirolimus in metastatic melanoma involves DKK1. Experimental dermatology 26 (7) (2018)
Tobias Sinnberg, Heike Niessner, Mitchell P Levesque, Christoph Dettweiler, Claus Garbe, Christian Busch
Embryonic bone morphogenetic protein and nodal induce invasion in melanocytes and melanoma cells. Biology open 7 (6) (2018)